SAR 40.1
(0.5%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 438.27 Million SAR | 13.14% |
2022 | 388.64 Million SAR | 63.29% |
2021 | 228.8 Million SAR | -14.78% |
2020 | 198.82 Million SAR | 15.55% |
2019 | 246.42 Million SAR | 9.9% |
2018 | 224.21 Million SAR | 18.75% |
2017 | 187.5 Million SAR | 90.11% |
2016 | 153.41 Million SAR | -36.55% |
2015 | 156.52 Million SAR | 16.59% |
2014 | 134.25 Million SAR | 6.8% |
2013 | 125.7 Million SAR | 18.4% |
2012 | 112.02 Million SAR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 81.92 Million SAR | -16.91% |
2024 Q1 | 100.82 Million SAR | 5.29% |
2024 Q2 | 89.41 Million SAR | -2.2% |
2023 Q3 | 111.61 Million SAR | -6.06% |
2023 Q4 | 98.64 Million SAR | -11.62% |
2023 Q1 | 117.78 Million SAR | 11.73% |
2023 FY | - SAR | 13.14% |
2023 Q2 | 118.81 Million SAR | 0.88% |
2022 Q1 | 96.27 Million SAR | 114.82% |
2022 FY | - SAR | 63.29% |
2022 Q4 | 105.41 Million SAR | 12.75% |
2022 Q3 | 93.49 Million SAR | -7.5% |
2022 Q2 | 101.08 Million SAR | 4.99% |
2021 Q3 | 80.25 Million SAR | 6.86% |
2021 FY | - SAR | -14.78% |
2021 Q4 | 44.81 Million SAR | -44.16% |
2021 Q1 | 70.53 Million SAR | 43.79% |
2021 Q2 | 75.1 Million SAR | 6.48% |
2020 FY | - SAR | 15.55% |
2020 Q4 | 49.05 Million SAR | -37.61% |
2020 Q3 | 78.63 Million SAR | -12.0% |
2020 Q2 | 89.34 Million SAR | 31.95% |
2020 Q1 | 67.71 Million SAR | 4.02% |
2019 FY | - SAR | 9.9% |
2019 Q1 | 62.08 Million SAR | 17.48% |
2019 Q2 | 59.18 Million SAR | -4.67% |
2019 Q4 | 65.09 Million SAR | 8.41% |
2019 Q3 | 60.04 Million SAR | 1.45% |
2018 Q4 | 52.85 Million SAR | -10.55% |
2018 Q2 | 31.04 Million SAR | -22.31% |
2018 Q1 | 39.95 Million SAR | 0.51% |
2018 Q3 | 59.08 Million SAR | 90.34% |
2018 FY | - SAR | 18.75% |
2017 FY | - SAR | 90.11% |
2017 Q2 | 58.15 Million SAR | -6.23% |
2017 Q1 | 62.02 Million SAR | 238.23% |
2017 Q3 | 34.32 Million SAR | -40.97% |
2017 Q4 | 39.75 Million SAR | 15.8% |
2016 Q2 | 26.86 Million SAR | -1.01% |
2016 Q3 | 26.98 Million SAR | 0.45% |
2016 Q4 | 18.33 Million SAR | -32.05% |
2016 FY | - SAR | -36.55% |
2016 Q1 | 27.13 Million SAR | -34.86% |
2015 Q2 | 38.4 Million SAR | -12.82% |
2015 Q1 | 44.05 Million SAR | 14.75% |
2015 FY | - SAR | 16.59% |
2015 Q4 | 41.65 Million SAR | 28.52% |
2015 Q3 | 32.41 Million SAR | -15.61% |
2014 Q4 | 38.39 Million SAR | 35.44% |
2014 Q2 | 39.23 Million SAR | -0.19% |
2014 Q1 | 39.3 Million SAR | 4.1% |
2014 FY | - SAR | 6.8% |
2014 Q3 | 28.34 Million SAR | -27.75% |
2013 Q4 | 37.75 Million SAR | 68.05% |
2013 Q3 | 22.46 Million SAR | -30.17% |
2013 Q2 | 32.17 Million SAR | -3.76% |
2013 Q1 | 33.43 Million SAR | 32.9% |
2013 FY | - SAR | 18.4% |
2012 FY | - SAR | 0.0% |
2012 Q4 | 25.15 Million SAR | 0.0% |
2012 Q3 | 25.15 Million SAR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Mouwasat Medical Services Company | 986.81 Million SAR | 55.586% |
Dallah Healthcare Company | 631.92 Million SAR | 30.644% |
National Medical Care Company | 323.02 Million SAR | -35.681% |
Middle East Healthcare Company | 551.23 Million SAR | 20.492% |
Dr. Sulaiman Al Habib Medical Services Group Company | 2.54 Billion SAR | 82.775% |
Canadian General Medical Center Complex Company | 19.92 Million SAR | -2099.811% |
Arabian International Healthcare Holding Company | 111.1 Million SAR | -294.467% |
Future Care Trading Co. | 15.6 Million SAR | -2708.021% |
Naba Alsaha Medical Services Company | 65.27 Million SAR | -571.391% |
Lana Medical Co. | 4.56 Million SAR | -9495.757% |
Al-Modawat Specialized Medical Co. | 20.76 Million SAR | -2010.308% |